Advertisement

Here's How Much You'd Have If You Invested $1000 in Intuitive Surgical, Inc. a Decade Ago

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and industries.

FOMO, or the fear of missing out, also plays a role in investing, particularly with tech giants and popular consumer-facing stocks.

What if you'd invested in Intuitive Surgical, Inc. (ISRG) ten years ago? It may not have been easy to hold on to ISRG for all that time, but if you did, how much would your investment be worth today?

Intuitive Surgical, Inc.'s Business In-Depth

With that in mind, let's take a look at Intuitive Surgical, Inc.'s main business drivers.

Headquartered Sunnyvale, CA, Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon’s console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging.

Intuitive Surgical’s robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The da Vinci System is powered by robotic technology which has provided the company with a solid exposure to Mechatronics, Robotocs and Artificial Intelligence for healthcare. The system provides 3-D High Definition vision, which helps surgeons gain superior visual clarity of target tissue and anatomy.

It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.  Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies.

The company operates through three segments: Instruments and Accessories, Systems and Services.

2021 Results at a Glance

Intuitive Surgical’s 2021 revenues totaled $5.71 billion, up 31% from 2020.

The company’s Instruments & Accessories sales were $3.10 billion (54.3% of net revenues), Systems revenues were $1.69 billion (29.7%) and Services revenues grossed $916.2 million (16%).

Bottom Line

While anyone can invest, building a lucrative investment portfolio takes research, patience, and a little bit of risk. If you had invested in Intuitive Surgical, Inc. ten years ago, you're probably feeling pretty good about your investment today.

According to our calculations, a $1000 investment made in November 2012 would be worth $4,090.99, or a gain of 309.10%, as of November 1, 2022, and this return excludes dividends but includes price increases.

In comparison, the S&P 500 gained 174.19% and the price of gold went up -8.53% over the same time frame.

Analysts are forecasting more upside for ISRG too.

Intuitive Surgical reported robust third-quarter results, beating estimates on both counts. The company’s da Vinci procedure volume demonstrated strong recovery in the first nine months of 2022, a trend likely to continue in upcoming quarter. The company’s revenue growth in the quarter under review reflected rise in revenues from procedures, system placements and services across all markets. Per management, strong U.S. dollar, lingering supply chain issues and inflation hurt operating margin. Despite this challenging environment, Intuitive Surgical witnessed healthy customer demand for its products in the quarter under review. A stable liquidity position is an added plus. It outperformed its industry so far this year. Yet, stiff competition in the global MedTech space and rising costs remain concerns for Intuitive Surgical.

Shares have gained 27.47% over the past four weeks and there have been 7 higher earnings estimate revisions for fiscal 2022 compared to none lower. The consensus estimate has moved up as well.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research